Literature DB >> 8440942

Parvovirus B19-specific DNA in bone marrow from B19 arthropathy patients: evidence for B19 virus persistence.

F Foto1, K G Saag, L L Scharosch, E J Howard, S J Naides.   

Abstract

To determine if B19 infection persists in patients with chronic B19 arthropathy, acute B19 infection in adults was documented by IgM serology. Bone marrow aspirates were obtained 24-42 months after acute infection in 4 patients who developed chronic joint symptoms. DNA from bone marrow aspirates was amplified by polymerase chain reaction by using B19-specific DNA sequences in the viral capsid gene and probing with B19-specific oligonucleotides in Southern analysis. B19-specific DNA sequences were detected in all 4 chronic arthropathy patients compared with 0 of 7 anti-B19 IgM-, IgG- and 0 of 6 anti-B19 IgM-, IgG+ normal bone marrow donors. Three patients with serologically proven acute B19 infection and acute but nonchronic joint symptoms had B19 DNA detected in bone marrow aspirates 2-18 months after infection. These findings suggest that B19 arthropathy is associated with persistence of either B19 virus or select B19 DNA sequences.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8440942     DOI: 10.1093/infdis/167.3.744

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  19 in total

1.  Genetic diversity within human erythroviruses: identification of three genotypes.

Authors:  Annabelle Servant; Syria Laperche; Francis Lallemand; Valérie Marinho; Guillemette De Saint Maur; Jean François Meritet; Antoine Garbarg-Chenon
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

2.  Comparative evaluation of virological and serological methods in prenatal diagnosis of parvovirus B19 fetal hydrops.

Authors:  M Zerbini; M Musiani; G Gentilomi; S Venturoli; G Gallinella; R Morandi
Journal:  J Clin Microbiol       Date:  1996-03       Impact factor: 5.948

3.  Detection of parvovirus B19 DNA in bone marrow cells by chemiluminescence in situ hybridization.

Authors:  M Musiani; A Roda; M Zerbini; G Gentilomi; P Pasini; G Gallinella; S Venturoli
Journal:  J Clin Microbiol       Date:  1996-05       Impact factor: 5.948

4.  Prevalence of parvovirus B19 and parvovirus V9 DNA and antibodies in paired bone marrow and serum samples from healthy individuals.

Authors:  Erik D Heegaard; Bodil Laub Petersen; Carsten J Heilmann; Allan Hornsleth
Journal:  J Clin Microbiol       Date:  2002-03       Impact factor: 5.948

5.  T helper cell-mediated interferon-gamma expression after human parvovirus B19 infection: persisting VP2-specific and transient VP1u-specific activity.

Authors:  R Franssila; J Auramo; S Modrow; M Möbs; C Oker-Blom; P Käpylä; M Söderlund-Venermo; K Hedman
Journal:  Clin Exp Immunol       Date:  2005-10       Impact factor: 4.330

Review 6.  Parvovirus B19 and chronic arthritis--causal or casual association?

Authors:  A D Woolf; B J Cohen
Journal:  Ann Rheum Dis       Date:  1995-07       Impact factor: 19.103

7.  Prenatal diagnosis of parvovirus B19-induced hydrops fetalis by chemiluminescence in situ hybridization.

Authors:  M Musiani; P Pasini; M Zerbini; G Gentilomi; A Roda; G Gallinella; E Manaresi; S Venturoli
Journal:  J Clin Microbiol       Date:  1999-07       Impact factor: 5.948

Review 8.  Parvovirus B19 infection.

Authors:  J R Kerr
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-01       Impact factor: 3.267

Review 9.  The evolution of small DNA viruses of eukaryotes: past and present considerations.

Authors:  F F Shadan; L P Villarreal
Journal:  Virus Genes       Date:  1995       Impact factor: 2.332

Review 10.  Human parvovirus B19.

Authors:  Erik D Heegaard; Kevin E Brown
Journal:  Clin Microbiol Rev       Date:  2002-07       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.